Sandro Pignata

No ORCID on file · 3 papers in corpus
review 2026
Clinical and translational medicine ·doi:10.1002/ctm2.70591

Angiogenesis, driven by the vascular endothelial growth factor (VEGF)/VEGFR signalling axis under hypoxic conditions, is one of the hallmarks of ovarian cancer (OC), contributing to tumour progression, metastatic dissemination and immune ev…

review 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1661048

Ovarian clear cell carcinoma (OCCC) is a rare, aggressive epithelial ovarian cancer subtype, accounting for approximately 10% of cases and associated with a poor prognosis due to chemoresistance and unique tumor biology. OCCC is frequently …

review 2019
Cancers ·doi:10.3390/cancers11111820

Endometrial cancer (EC) is the most frequent gynecological cancer. In patients with relapsed and advanced disease, prognosis is still dismal and development of resistance is common. In this context, endometrial Cancer Stem Cells (eCSC), ste…